- GlobeNewswire•5 days agoAthersys Subsidiary and Leading Animal Health Company Enter Into Research and Option Agreement for Cell Therapy
CLEVELAND, Jan. 18, 2017-- Athersys, Inc. announced today that through its Belgian subsidiary, ReGenesys BVBA, it has entered into an agreement with a global leader in the animal health business segment ...
- Capital Cube•25 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Athersys, Inc. Here are 5 ETFs with the largest exposure to ATHX-US. Comparing the performance and risk of Athersys, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- Zacks•last month
Ironwood (IRWD) and Allergan (AGN) report phase IIb study data on colonic release formulations of Linzess for the treatment of irritable bowel syndrome with constipation.
ATHX : Summary for Athersys, Inc. - Yahoo Finance
Athersys, Inc. (ATHX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||1.41 - 1.46|
|52 Week Range||1.14 - 2.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-24.41|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|